The authors speculated that CD40L-related enhancement of inflammation and coagulation theoretically might increase the risk of restenosis and in-stent thrombosis in CAD patients and, as a prove, referred to several studies that found associations between restenosis and the CD40 system (125–127). This evidence concerns the gene CD40LG and coronary artery disorder.